Oxford Global R&D Series: VIRTUAL
About the event: Oxford Global R&D Series
POSTPONED to 29-30 July 2020 as a virtual event
The R&D Series features 3 outstanding programmes bringing together Europe’s most successful pharmaceutical organisations, top biotech companies and internationally renowned academic institutions specialising in therapeutic areas. The event includes over 100 cutting-edge presentations and workshops, over 8 hours of valuable networking sessions, and an exhibition hall showcasing 40 vendor companies.
Taros’ participants
Taros’ Drug Discovery Experts are invited to share their outstanding industry expertise with other professional from industry and academia
Dr. Dimitrios Tzalis, CEO as speaker on “the European Lead Factory (ELF) – the success story continues” within a virtual round table session on Drug Discovery Partnership Models Interactive Panel discussion and Open Address
Dr. Torsten Hoffmann, SVP Drug Discovery as invited Keynote Lecturer: “From Small Molecules, To Peptide Therapeutics And Oligoribonucleotides – 3 Short Stories In Drug Discovery”
Looks interesting?
As a leading CRO in Europe, Taros provides comprehensive drug discovery chemistry services for large Pharma and Biotech corporations as well as for Research Institutes and Academia
Our experienced chemists practice a pragmatic culture and customer-centric approach in order to exceed project expectations and, despite challenges, bridge very narrow timelines. They are trained to consider economic, safety and ecological boundaries and conditions laid out for all stages of the project.
